What are the latest treatment options for Parkinson’s disease?

Written in association with: Dr Claudio Ruffmann
Published:
Edited by: Conor Lynch

In this article below, distinguished consultant neurologist Dr Claudio Ruffmann discusses Parkinson’s disease at length, including the newest treatment options for the condition.

How has knowledge about Parkinson’s disease advanced over recent years?

Knowledge regarding Parkinson’s disease has advanced exponentially over recent years. This is because multiple avenues of research have been opened, ranging from diagnosis and causes to management and treatment options of the condition. 

 

Parkinson’s disease was first discovered and described over 200 years ago, so since then, we have now come to a point where we know a lot thanks to the developments in research. I think our understanding the molecular mechanisms of Parkinson’s disease has greatly improved, and we have better adapted our understanding of what the patient with Parkinson's disease is experience. 

 

 

What are the latest treatment options for Parkinson’s disease?

We have had a game-changing medication for 50 years now, called levodopa. It has been so effective that it has been quite difficult to find a replicate since. However, we have made advancements when it comes to managing the condition. The non-oral treatments (including deep brain stimulation) for Parkinson’s have been fine-tuned a lot. We really try to keep dopamine as stable as possible. We can do this by developing new molecules.

 

 

What are those involved in Parkinson’s research currently investigating?

One of the things they are looking at is why a very specific part of the brain and specific part of nerve cells are involved in the degeneration, and why these cells die and others don't. Finding the answer to this would allow us to develop a specific treatment for this.

 

Another area that we are researching is a potential cure for Parkinson’s disease. Two of the important areas in this include stem-cell research (replacing lost cells) and immunotherapy.

 

 

Is the rate of Parkinson’s disease on the rise? If so, why?

This is a debated question. The risk of Parkinson’s disease increases with age. We have become much more aware of the condition recently, so we can now diagnose it earlier and easier. I think an increasing prevalence of the disease can be contributed to an increasing age of our population.

 

 

What does the future of Parkinson’s treatment look like?

I think the future of treatment for Parkinson’s will be based mainly on the concept of tailoring treatment to the individual’s needs. There is a wide age range, so someone in their 30s will have very different needs compared to someone with the condition in their 60s or 70s.

 

 

 

If you’d like to schedule an appointment with Dr Ruffman, simply visit his Top Doctors profile today.

By Dr Claudio Ruffmann
Neurology

Dr Claudio Ruffmann is a leading consultant neurologist based in Hampshire. He is renowned for his expertise in Parkinson’s disease and movement disorders. He also specialises in the treatment of headache, epilepsy, dizziness and tremor.

Dr Ruffmann obtained his primary medical qualification at the University of Milano-Bicocca in Italy before undergoing specialist training in neurology. After relocating to the UK, he conducted research at Imperial College London on the neuropathology of dementia in Parkinson's disease. He additionally obtained a PhD in 2018 from the University of Oxford, where he studied potential biomarkers of Parkinson’s disease. He was also previously a clinical research fellow at Imperial College London, where he studied the neuropathology of Parkinson’s disease. Dr Ruffmann works within Hampshire Hospitals NHS Foundation Trust as a consultant neurologist and is also an honorary consultant neurologist at University Hospital Southampton. He currently sees private patients at the Candover Clinic.

Dr Ruffmann has conducted a wealth of research throughout his career in affiliation with the University of Oxford, Imperial College London and Italy’s Istituti Clinici di Perfezionamento. His work is published in peer-reviewed academic journals.

View Profile

Overall assessment of their patients


  • Related procedures
  • Botulinum toxin (Botox™)
    Neuropsychology
    Sleep disorders
    Learning disabilities
    Tinnitus
    Obstructive sleep apnea
    Neurological treatments
    Chronic headache
    Neuropathic pain
    Epilepsy
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.